A potential corona vaccine was developed in record time. Huge advances in medicine should also help cancer patients.
- Pharmaceutical companies Biontech and Pfizer have a very promising Corona * –vaccine developed.
- The remedy can also be used in treatment Cancer Help.
- Unlike influenza vaccination, vaccination is performed entirely in the laboratory.
Kassel – The New corona infections in Germany, despite the blockage, “light” is growing rapidly. Pharmaceutical companies are working on one vaccine. He could now Corona vaccine of Biontech and Pfizer be the solution. It should now offer 95% protection. Developments in record time could as well Cancer– Benefits for patients.
The so-called mRNA vaccine will be approved soon. It does not contain vaccinations Coronavirus alone, but only genetic information. It reports “focus.de“In contrast, with influenza vaccination, patients are injected with influenza viruses – in an attenuated form. This causes the immune system to produce antibodies.” Corona vaccination only “construction instructions” enter the body. Antibodies can also be generated in this manner.
Corona vaccine: laboratory production possible
Another plus point vaccination: It can be produced completely in the laboratory and in large quantities. On Flu vaccination looks different. Viruses mature in several hundred million chicken eggs each year. This is much more complicated and requires more time.
We made it to the finals #efficiency mark for analysis, indicating a high degree of protection against # COVID-19 can be achieved very quickly after the second dose of 30 µg. We will share more details with @EMA_News, @US_FDA and other regulatory authorities. https://t.co/6toskNDTEP pic.twitter.com/TsCQP4Nsb0
– BioNTech SE (@BioNTech_Group) November 18, 2020
Development mRNA vaccines also offers for Cancer research significant benefit. Dirk Jäger, head of the medical oncology department at the National Cancer Center in Heidelberg, explains:focus.de“Treatment can be much faster and cheaper.” “With mRNA technology, it would be possible to produce a suitable cancer drug in four to six weeks.” The process is not as expensive as producing a protein vaccine with the necessary purity, ”explains Jäger.
Unlike Corona: Cancer patients require individual treatment
But I need one Krebs patient, Unlike Coronaindividual drug. This must be adapted to the tumor mutation. The mRNA method could significantly reduce effort. Developing potential Corona vaccine Many other medical areas can benefit.
Possible vaccine not primarily in front of one Oncological diseases defend. Rather, existing tumors can be fought. Patients often have small residues in the body after surgical removal of the tumor. In this way, the vaccine can effectively remove tumor debris, says the doctor.
After corona vaccination: the cancer vaccine does not replace traditional therapy
Every week or two Krebs patient AND vaccination obtained to stimulate the body’s immune response. Later much less often. However, affected individuals must first undergo conventional therapy, such as chemotherapy. Replaces and vaccine So no therapy, just supplement it.
However, they are Cancer cells, otherwise if Coronaviruses, no foreign viruses. Cancer cells are mutated cells in your own body. They multiply in an uncontrolled way and can grow into healthy tissue. This creates considerable difficulties. Thus, it will take some time before an effective cancer vaccine can be developed. It still means developing potential Corona vaccine great advances in medicine.
Your opinion is requested!
Cancer vaccines are already available
In the meantime, they already exist Vaccineswhich can protect against cancer, for example on cervical cancer. The disease is caused by viruses – the so-called human papillomavirus (HPV). To avoid against Liver cancer there is vaccination against hepatitis. (cheese) * hna.de is part of the nationwide digital content management network Ippen.
Picture of a list of headings: © Hans Pennink / dpa